leisure time -WSS

leisure time

author：explore 2025-10-01 16:42:31 - browse：73

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Surgeons perform first xenotransplant using CRISPR'd pig kidney

WSS

Biotech investment managers search for lucrative opportunities

Medical devices makers are asking for forgiveness, not permission

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

With Wegovy coverage, Medicare patients may face high costs

Erich Jarvis studies song birds to learn about human stuttering

Indian pharmaceutical industry in denial over drug

explore

leisure time

knowledge

Tori Bowie and the unacceptable rates of Black maternal death

Mass General totes up its waste in a move to tackle climate change

At least 13 dead in Texas as scorching temps continue

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Yancopoulos of Regeneron works to expand Dupixent success

Jerome Adams on the need for new antivirals for Covid

Mirador, a new biotech startup, launches with $400 million

knowledge

Stanford president's case begs question: Who takes blame?

I learned firsthand about improving diversity in clinical trials

Ending racial health disparities hinges on penalties, political will

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Adam's Take: Intra

Bring on the sabbaticals for nurses

focus

leisure time

hotspot

hotspot